Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: Results of the German IGLU follow-up study 2001

Helmuth G. Doerr; M. Bettendorf; B. P. Hauffa; Otto Mehls; C. J. Partsch; Elfriede Said; Sabine Sander; H. P. Schwarz; N. Stahnke; Heiner Steinkamp; Michael B. Ranke; H. I. Akkurt; W. Andler; M. Becker; H. J. Böhles; J. Brämswig; O. Butenandt; M. Bettendorf; H. G. Doerr; J. H.H. Ehrich; B. Erxleben; B. Griefahn; A. Grueters; K. Hartmann; B. P. Hauffa; F. Haverkamp; W. Hecker; U. Heinrich; G. K. Hinkel; O. Hiort; R. Holl; J. Homoki; G. Horneff; U. Irle; R. Johs; C. Jourdan; E. Keller; J. Kerstan; E. Korsch; J. Kreuder; H. P. Krohn; F. Krull; D. Kunze; M. Lakomek; D. Lenz; U. Leuthold; M. Mix; K. Mohnike; M. Morlot; R. Mühlenberg; H. Müller; C. J. Partsch; M. Pavlovic; K. Rager; M. B. Ranke; W. Rauh; H. J. Rickers; B. Schenk; D. Schnabel; E. Schönau; H. P. Schwarz; G. Skimic-Schleicher; W. G. Sippell; N. Stahnke; M. Teufel; W. Tillmann; B. Tittel; U. Tuschy; K. P. Ullrich; W. von Petrikowsky; H. P. Weber; K. Wesseler; R. P. Willig; J. Wintgens; M. Witsch

doi:10.1093/humrep/deh764

Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: Results of the German IGLU follow-up study 2001

Helmuth G. Doerr, M. Bettendorf, B. P. Hauffa, Otto Mehls, C. J. Partsch, Elfriede Said, Sabine Sander, H. P. Schwarz, N. Stahnke, Heiner Steinkamp, Michael B. Ranke, H. I. Akkurt, W. Andler, M. Becker, H. J. Böhles, J. Brämswig, O. Butenandt, M. Bettendorf, H. G. Doerr, J. H.H. EhrichB. Erxleben, B. Griefahn, A. Grueters, K. Hartmann, B. P. Hauffa, F. Haverkamp, W. Hecker, U. Heinrich, G. K. Hinkel, O. Hiort, R. Holl, J. Homoki, G. Horneff, U. Irle, R. Johs, C. Jourdan, E. Keller, J. Kerstan, E. Korsch, J. Kreuder, H. P. Krohn, F. Krull, D. Kunze, M. Lakomek, D. Lenz, U. Leuthold, M. Mix, K. Mohnike, M. Morlot, R. Mühlenberg, H. Müller, C. J. Partsch, M. Pavlovic, K. Rager, M. B. Ranke, W. Rauh, H. J. Rickers, B. Schenk, D. Schnabel, E. Schönau, H. P. Schwarz, G. Skimic-Schleicher, W. G. Sippell, N. Stahnke, M. Teufel, W. Tillmann, B. Tittel, U. Tuschy, K. P. Ullrich, W. von Petrikowsky, H. P. Weber, K. Wesseler, R. P. Willig, J. Wintgens, M. Witsch

Klinik für Kinder- und Jugendmedizin

42 Zitate (Scopus)

Abstract

Background: To evaluate the factors influencing uterine size in young adult women with Turner syndrome (TS) after long-term growth hormone (GH) treatment. Methods: Cross-sectional study. Out of 188 women with TS from 96 German centres, whose longitudinal growth was documented within KIGS (Pfizer International Growth Database), data on uterine size were collected voluntarily at a standardized follow-up visit: 75 TS women (ages: 15.8-30.8 years) with complete data were included. Classification according to karyotype: 45,X (78.6%), 45,X/46,XX (5.4%), 45,X/46,iXq (8%), 45,X/46,XY (8%). Puberty was induced with estrogens in all women. At follow-up, 66 were on cyclic estrogens and progestins. Results: 13/66 (19.6%) TS women who received estrogens had a reduced uterine length <5cm. Calculating the data in standard deviation scores (SDS), only women with 45,X/46,XX karyotype had normal median uterine length and volume of 0.6 and 1.59 SDS respectively. An incomplete breast development (Tanner stage B 3) was found in women with 45,X karyotype (n = 11; 18.6%) and with 45,X/46,XY (n = 2). Conclusions: Only TS women with karyotype 45,X/46,XX had normal uterine sizes, whereas 26% of the TS women with karyotype 45,X had a uterine length <-2 SDS, and 18% a volume <-2 SDS.

Originalsprache	Englisch
Zeitschrift	Human Reproduction
Jahrgang	20
Ausgabenummer	5
Seiten (von - bis)	1418-1421
Seitenumfang	4
ISSN	0268-1161
DOIs	https://doi.org/10.1093/humrep/deh764
Publikationsstatus	Veröffentlicht - 05.2005

Strategische Forschungsbereiche und Zentren

Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

Zugriff auf Dokument

10.1093/humrep/deh764

Andere Dateien und Links

Link to publication in Scopus

Zitieren

Doerr, H. G., Bettendorf, M., Hauffa, B. P., Mehls, O., Partsch, C. J., Said, E., Sander, S., Schwarz, H. P., Stahnke, N., Steinkamp, H., Ranke, M. B., Akkurt, H. I., Andler, W., Becker, M., Böhles, H. J., Brämswig, J., Butenandt, O., Bettendorf, M., Doerr, H. G., ... Witsch, M. (2005). Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: Results of the German IGLU follow-up study 2001. Human Reproduction, 20(5), 1418-1421. https://doi.org/10.1093/humrep/deh764

@article{0ce030c2213a438b9f32e9137450292c,

title = "Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: Results of the German IGLU follow-up study 2001",

abstract = "Background: To evaluate the factors influencing uterine size in young adult women with Turner syndrome (TS) after long-term growth hormone (GH) treatment. Methods: Cross-sectional study. Out of 188 women with TS from 96 German centres, whose longitudinal growth was documented within KIGS (Pfizer International Growth Database), data on uterine size were collected voluntarily at a standardized follow-up visit: 75 TS women (ages: 15.8-30.8 years) with complete data were included. Classification according to karyotype: 45,X (78.6%), 45,X/46,XX (5.4%), 45,X/46,iXq (8%), 45,X/46,XY (8%). Puberty was induced with estrogens in all women. At follow-up, 66 were on cyclic estrogens and progestins. Results: 13/66 (19.6%) TS women who received estrogens had a reduced uterine length <5cm. Calculating the data in standard deviation scores (SDS), only women with 45,X/46,XX karyotype had normal median uterine length and volume of 0.6 and 1.59 SDS respectively. An incomplete breast development (Tanner stage B 3) was found in women with 45,X karyotype (n = 11; 18.6%) and with 45,X/46,XY (n = 2). Conclusions: Only TS women with karyotype 45,X/46,XX had normal uterine sizes, whereas 26% of the TS women with karyotype 45,X had a uterine length <-2 SDS, and 18% a volume <-2 SDS.",

author = "Doerr, {Helmuth G.} and M. Bettendorf and Hauffa, {B. P.} and Otto Mehls and Partsch, {C. J.} and Elfriede Said and Sabine Sander and Schwarz, {H. P.} and N. Stahnke and Heiner Steinkamp and Ranke, {Michael B.} and Akkurt, {H. I.} and W. Andler and M. Becker and B{\"o}hles, {H. J.} and J. Br{\"a}mswig and O. Butenandt and M. Bettendorf and Doerr, {H. G.} and Ehrich, {J. H.H.} and B. Erxleben and B. Griefahn and A. Grueters and K. Hartmann and Hauffa, {B. P.} and F. Haverkamp and W. Hecker and U. Heinrich and Hinkel, {G. K.} and O. Hiort and R. Holl and J. Homoki and G. Horneff and U. Irle and R. Johs and C. Jourdan and E. Keller and J. Kerstan and E. Korsch and J. Kreuder and Krohn, {H. P.} and F. Krull and D. Kunze and M. Lakomek and D. Lenz and U. Leuthold and M. Mix and K. Mohnike and M. Morlot and R. M{\"u}hlenberg and H. M{\"u}ller and Partsch, {C. J.} and M. Pavlovic and K. Rager and Ranke, {M. B.} and W. Rauh and Rickers, {H. J.} and B. Schenk and D. Schnabel and E. Sch{\"o}nau and Schwarz, {H. P.} and G. Skimic-Schleicher and Sippell, {W. G.} and N. Stahnke and M. Teufel and W. Tillmann and B. Tittel and U. Tuschy and Ullrich, {K. P.} and {von Petrikowsky}, W. and Weber, {H. P.} and K. Wesseler and Willig, {R. P.} and J. Wintgens and M. Witsch",

year = "2005",

month = may,

doi = "10.1093/humrep/deh764",

language = "English",

volume = "20",

pages = "1418--1421",

journal = "Human Reproduction",

issn = "0268-1161",

number = "5",

}

Doerr, HG, Bettendorf, M, Hauffa, BP, Mehls, O, Partsch, CJ, Said, E, Sander, S, Schwarz, HP, Stahnke, N, Steinkamp, H, Ranke, MB, Akkurt, HI, Andler, W, Becker, M, Böhles, HJ, Brämswig, J, Butenandt, O, Bettendorf, M, Doerr, HG, Ehrich, JHH, Erxleben, B, Griefahn, B, Grueters, A, Hartmann, K, Hauffa, BP, Haverkamp, F, Hecker, W, Heinrich, U, Hinkel, GK, Hiort, O, Holl, R, Homoki, J, Horneff, G, Irle, U, Johs, R, Jourdan, C, Keller, E, Kerstan, J, Korsch, E, Kreuder, J, Krohn, HP, Krull, F, Kunze, D, Lakomek, M, Lenz, D, Leuthold, U, Mix, M, Mohnike, K, Morlot, M, Mühlenberg, R, Müller, H, Partsch, CJ, Pavlovic, M, Rager, K, Ranke, MB, Rauh, W, Rickers, HJ, Schenk, B, Schnabel, D, Schönau, E, Schwarz, HP, Skimic-Schleicher, G, Sippell, WG, Stahnke, N, Teufel, M, Tillmann, W, Tittel, B, Tuschy, U, Ullrich, KP, von Petrikowsky, W, Weber, HP, Wesseler, K, Willig, RP, Wintgens, J & Witsch, M 2005, 'Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: Results of the German IGLU follow-up study 2001', Human Reproduction, Jg. 20, Nr. 5, S. 1418-1421. https://doi.org/10.1093/humrep/deh764

Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: Results of the German IGLU follow-up study 2001. / Doerr, Helmuth G.; Bettendorf, M.; Hauffa, B. P. et al.
in: Human Reproduction, Jahrgang 20, Nr. 5, 05.2005, S. 1418-1421.

Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

TY - JOUR

T1 - Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: Results of the German IGLU follow-up study 2001

AU - Doerr, Helmuth G.

AU - Bettendorf, M.

AU - Hauffa, B. P.

AU - Mehls, Otto

AU - Partsch, C. J.

AU - Said, Elfriede

AU - Sander, Sabine

AU - Schwarz, H. P.

AU - Stahnke, N.

AU - Steinkamp, Heiner

AU - Ranke, Michael B.

AU - Akkurt, H. I.

AU - Andler, W.

AU - Becker, M.

AU - Böhles, H. J.

AU - Brämswig, J.

AU - Butenandt, O.

AU - Bettendorf, M.

AU - Doerr, H. G.

AU - Ehrich, J. H.H.

AU - Erxleben, B.

AU - Griefahn, B.

AU - Grueters, A.

AU - Hartmann, K.

AU - Hauffa, B. P.

AU - Haverkamp, F.

AU - Hecker, W.

AU - Heinrich, U.

AU - Hinkel, G. K.

AU - Hiort, O.

AU - Holl, R.

AU - Homoki, J.

AU - Horneff, G.

AU - Irle, U.

AU - Johs, R.

AU - Jourdan, C.

AU - Keller, E.

AU - Kerstan, J.

AU - Korsch, E.

AU - Kreuder, J.

AU - Krohn, H. P.

AU - Krull, F.

AU - Kunze, D.

AU - Lakomek, M.

AU - Lenz, D.

AU - Leuthold, U.

AU - Mix, M.

AU - Mohnike, K.

AU - Morlot, M.

AU - Mühlenberg, R.

AU - Müller, H.

AU - Partsch, C. J.

AU - Pavlovic, M.

AU - Rager, K.

AU - Ranke, M. B.

AU - Rauh, W.

AU - Rickers, H. J.

AU - Schenk, B.

AU - Schnabel, D.

AU - Schönau, E.

AU - Schwarz, H. P.

AU - Skimic-Schleicher, G.

AU - Sippell, W. G.

AU - Stahnke, N.

AU - Teufel, M.

AU - Tillmann, W.

AU - Tittel, B.

AU - Tuschy, U.

AU - Ullrich, K. P.

AU - von Petrikowsky, W.

AU - Weber, H. P.

AU - Wesseler, K.

AU - Willig, R. P.

AU - Wintgens, J.

AU - Witsch, M.

PY - 2005/5

Y1 - 2005/5

N2 - Background: To evaluate the factors influencing uterine size in young adult women with Turner syndrome (TS) after long-term growth hormone (GH) treatment. Methods: Cross-sectional study. Out of 188 women with TS from 96 German centres, whose longitudinal growth was documented within KIGS (Pfizer International Growth Database), data on uterine size were collected voluntarily at a standardized follow-up visit: 75 TS women (ages: 15.8-30.8 years) with complete data were included. Classification according to karyotype: 45,X (78.6%), 45,X/46,XX (5.4%), 45,X/46,iXq (8%), 45,X/46,XY (8%). Puberty was induced with estrogens in all women. At follow-up, 66 were on cyclic estrogens and progestins. Results: 13/66 (19.6%) TS women who received estrogens had a reduced uterine length <5cm. Calculating the data in standard deviation scores (SDS), only women with 45,X/46,XX karyotype had normal median uterine length and volume of 0.6 and 1.59 SDS respectively. An incomplete breast development (Tanner stage B 3) was found in women with 45,X karyotype (n = 11; 18.6%) and with 45,X/46,XY (n = 2). Conclusions: Only TS women with karyotype 45,X/46,XX had normal uterine sizes, whereas 26% of the TS women with karyotype 45,X had a uterine length <-2 SDS, and 18% a volume <-2 SDS.

AB - Background: To evaluate the factors influencing uterine size in young adult women with Turner syndrome (TS) after long-term growth hormone (GH) treatment. Methods: Cross-sectional study. Out of 188 women with TS from 96 German centres, whose longitudinal growth was documented within KIGS (Pfizer International Growth Database), data on uterine size were collected voluntarily at a standardized follow-up visit: 75 TS women (ages: 15.8-30.8 years) with complete data were included. Classification according to karyotype: 45,X (78.6%), 45,X/46,XX (5.4%), 45,X/46,iXq (8%), 45,X/46,XY (8%). Puberty was induced with estrogens in all women. At follow-up, 66 were on cyclic estrogens and progestins. Results: 13/66 (19.6%) TS women who received estrogens had a reduced uterine length <5cm. Calculating the data in standard deviation scores (SDS), only women with 45,X/46,XX karyotype had normal median uterine length and volume of 0.6 and 1.59 SDS respectively. An incomplete breast development (Tanner stage B 3) was found in women with 45,X karyotype (n = 11; 18.6%) and with 45,X/46,XY (n = 2). Conclusions: Only TS women with karyotype 45,X/46,XX had normal uterine sizes, whereas 26% of the TS women with karyotype 45,X had a uterine length <-2 SDS, and 18% a volume <-2 SDS.

UR - http://www.scopus.com/inward/record.url?scp=20344380670&partnerID=8YFLogxK

U2 - 10.1093/humrep/deh764

DO - 10.1093/humrep/deh764

M3 - Journal articles

C2 - 15695313

AN - SCOPUS:20344380670

SN - 0268-1161

VL - 20

SP - 1418

EP - 1421

JO - Human Reproduction

JF - Human Reproduction

IS - 5

ER -

Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: Results of the German IGLU follow-up study 2001

Abstract

Strategische Forschungsbereiche und Zentren

UN SDGs

Zugriff auf Dokument

Andere Dateien und Links

Fingerprint

Zitieren